JLE

Epileptic Disorders

MENU

Epilepsy, interictal EEG abnormalities and hippocampal atrophy in patients with calcified neurocysticercosis: a population study in an endemic milieu Volume 23, issue 2, April 2021

  • [1] Coyle C.M. Neurocysticercosis: an update. Curr Infect Dis Rep. 2014;16:437.
  • [2] Garcia H.H., Nash T.E., Del Brutto O.H. Clinical symptoms, diagnosis, and treatment of neurocysticercosis. Lancet Neurol. 2014;13:1202-1215.
  • [3] Debacq G., Moyano L.M., Garcia H.H., Boumediene F., Marin B., Ngoungou E.B. Systematic review and meta-analysis estimating association of cysticercosis and neurocysticercosis with epilepsy. PLoS Negl Trop Dis. 2017;11:e0005153. 3
  • [4] Moyano L.M., Saito M., Montano S.M., Gonzalvez G., Olaya S., Ayvar V. Neurocysticercosis as a cause of epilepsy and seizures in two community-based studies in a cysticercosis-endemic region in Perú. PLoS Negl Trop Dis. 2014;8:e2692.
  • [5] Del Brutto O.H., Santibañez R., Noboa C.A., Aguirre R., Díaz E., Alarcón T.A. Epilepsy due to neurocysticercosis: analysis of 203 patients. Neurology. 1992;42:389-392.
  • [6] Nash T.E., Mahanty S., Loeb J.A., Theodore W.H., Friedman A., Sander J.A. Neurocysticercosis: a natural human model of epileptogenesis. Epilepsia. 2015;56:177-183.
  • [7] Cukiert A., Puglia P., Scapolan H.B., Vilela M.M., Marino Júnior R. Congruence of the topography of intracranial calcifications and epileptic foci. Arq Neuropsiquiatr. 1994;52:289-294.
  • [8] Nash T.E., Pretell E.J., Lescano A.G., Bustos J.A., Gilman R.H., Gonzalez A.E. Perilesional oedema and seizure activity in patients with calcified neurocysticercosis: a prospective cohort and nested case-control Study. Lancet Neurol. 2008;7:1099-1105.
  • [9] Del Brutto O.H., Arroyo G., Del Brutto V.J., Zambrano M., Garcia H.H. On the relationship between calcified neurocysticercosis and epilepsy in an endemic village: a large-scale, computed tomography-based population study in rural Ecuador. Epilepsia. 2017;58:1955-1961.
  • [10] Bianchin M.M., Velasco T.R., Santos A.C., Sakamoto A.C. On the relationship between neurocysticercosis and mesial temporal lobe epilepsy associated with hippocampal sclerosis: coincidence or a pathogenic relationship. Pathog Glob Health. 2012;106:280-285.
  • [11] Bianchin M.M., Velasco T.R., Wichert-Ana L., Araújo D. Jr., Alexandre V. Jr., Scornavacca F. Neuroimaging observations linking neurocysticercosis and mesial temporal lobe epilepsy with hippocampal sclerosis. Epilepsy Res. 2015;116:34-39.
  • [12] Del Brutto O.H., Salgado P., Lama J., Del Brutto V.J., Campos X., Zambrano M. Calcified neurocysticercosis associates with hippocampal atrophy: a population-based study. Am J Trop Med Hyg. 2015;92:64-68.
  • [13] Del Brutto O.H., Issa N.P., Salgado P., Del Brutto V.J., Zambrano M., Lama J. The association between neurocysticercosis and hippocampal atrophy is related to age. Am J Trop Med Hyg. 2017;96:243-248.
  • [14] Del Brutto O.H., Mera R.M. The importance of people compliance (social desirability bias) in the assessment of epilepsy in rural areas of developing countries. Results of the Atahualpa Project. Epilepsia. 2016;57:e221-e224. for the Atahualpa Project Investigators
  • [15] Issa N.P., Sedler M.J., Del Brutto V.J., Darsan E., Milla L., Montes J. EEG patterns in patients with calcified neurocysticercosis with and without hippocampal atrophy. J Clin Neurophysiol. 2018;35:332-338.
  • [16] Del Brutto O.H., Santibáñez R., Idrovo L., Rodríguez S., Díaz-Calderón E., Navas C. Epilepsy and neurocysticercosis in Atahualpa: a door-to-door survey in rural coastal Ecuador. Epilepsia. 2005;46:583-587.
  • [17] Del Brutto O.H., Mera R.M., Castillo P.R., Del Brutto V.J. Key findings from the Atahualpa Project: what should we learn? Expert Rev Neurother. 2018;18:5-8.
  • [18] Del Brutto O.H., O’Neal S.E., Dorny P., García H.H. Spontaneously arrested transmission of cysticercosis in a highly endemic village with a very low migration rate. Am J Trop Med Hyg. 2018;98:776-778.
  • [19] Bennett D.A., Brayne C., Feigin V.L., Barker-Collo S., Brainin M., Davis D. Development of the standards of reporting of neurological disorders (STROND) checklist: a guideline for the reporting of incidence and prevalence studies in neuroepidemiology. Neurology. 2015;85:821-828.
  • [20] Placencia M., Sander J.W., Shorvon S.D., Ellison R.H., Cascante S.M. Validation of a screening questionnaire for the detection of epileptic seizures in epidemiological studies. Brain. 1992;115:783-794.
  • [21] Del Brutto O.H., Nash T.E., White A.C. Jr., Rajshekhar V., Wilkins P.P., Singh G. Revised diagnostic criteria for neurocysticercosis. J Neurol Sci. 2017;372:202-210.
  • [22] Scheltens P.H., Leys D., Barkhof F., Huglo D., Weinstein H.C., Vermersch P. Atrophy of medical temporal lobes on MRI in “probable” Alzheimer's disease and normal ageing: diagnostic value and neuropsychological correlates. J Neurol Neurosurg Psychiatry. 1992;55:967-972.
  • [23] Ikeda A, Klem GH, Luders HO. Metabolic, infectious, and hereditary encephalopathies. In: Ebersole JS, Pedley TA, eds. Current Practice of Clinical Electroencephalography. 3rd ed. Philadelphia, PA: Lippincott Williams & Wilkins, 2014; 348-377.
  • [24] Wardlaw J.M., Smith E.E., Biessels G.J., Cordonnier C., Fazekas F., Frayne R. Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol. 2013;12:822-838.
  • [25] Velasco T.R., Zanello P.A., Dalmagro C.L., Araújo D. Jr., Santos A.C., Bianchin M.M. Calcified cysticercosis lesions and intractable epilepsy: a cross sectional study of 512 patients. J Neurol Neurosurg Psychiatry. 2006;77:485-488.
  • [26] Bianchin M.M., Velasco T.R., Wichert-Ana L., Dos Santos A.C., Sakamoto A.C. Understanding the association of neurocysticercosis and mesial temporal lobe epilepsy and its impact on the surgical treatment of patients with drug-resistant epilepsy. Epilepsy Behav. 2017;76:168-177.
  • [27] Bianchin M.M., Velasco T.R., Takayanagui O.M., Sakamoto A.C. Neurocysticercosis, mesial temporal lobe epilepsy, and hippocampal sclerosis: an association largely ignored. Lancet Neurol. 2006;5:20-21.
  • [28] Del Brutto O.H., Engel J. Jr., Eliashiv D., García H.H. Update on cysticercosis epileptogenesis: the role of the hippocampus. Curr Neurol Neurosci Rep. 2016;16:1.
  • [29] Balthazar M.L.F., Kobayashi E., Dantas C.R., Ghizoni E., Marques L.H.N., Santos S.L.M. Neurocysticercosis calcifications in patients with partial epilepsy: is there etiological relevance? J Epilepsy Clin Neurophysiol. 2002;8:217-220.
  • [30] Bembadis S.R., Wallace J., Murtagh F.R., Martinez C., Tatum W.O., Vale F.L. MRI evidence of mesial temporal sclerosis in subjects without seizures. Seizures. 2002;11:340-343.
  • [31] Menzler K., Iwinska-Zelder J., Shiratori K., Jaeger R.K., Oertel W.H., Hamer H.M. Evaluation of MRI criteria (1.5 T) for the diagnosis of hippocampal sclerosis in healthy subjects. Epilepsy Res. 2010;89:349-354.
  • [32] Moore K.R., Swallow C.E., Tsuruda J.S. Incidental detection of hippocampal sclerosis on MR images: is it significant? AJNR Am J Neuroradiol. 1999;20:1609-1612.
  • [33] Koessler L., Cecchin T., Colnat-Coulbois S., Vignal J.P., Jonas J., Vespignani H. Catching the invisible: mesial temporal source contribution to simultaneous EEG and SEEG recordings. Brain Topogr. 2015;28:5-20.
  • [34] Wennberg R., Valiante T., Cheyne D. EEG and MEG in mesial temporal lobe epilepsy: where do spikes come from? Clin Neurophysiol. 2011;122:1295-1313.
  • [35] Luna J., Nizars M., Becker D., Gerard D., Cruz A., Ratsimbazafy V. Epilepsy- associated levels of perceived stigma, their associations with treatment, and related factors: a cross-sectional study in urban and rural areas in Ecuador. Epilepsy Behav. 2017;68:71-77.
  • [36] Del Brutto O.H., Engel J. Jr., Eliashiv D.S., Salamon N., García H.H. Hippocampal sclerosis: the missing link of cysticercosis epileptogenesis. Epilepsia. 2014;55:2077-2078.
  • [37] Ooi W.W., Wijemanne S., Thomas C.B., Quezado M., Brown C.R., Nash T.E. A calcified Taenia solium granuloma associated with recurrent perilesional edema causing refractory seizures: histopathological features. Am J Trop Med Hyg. 2011;85:460-463.
  • [38] Nash T.E., Bartelt L.A., Korpe P.S., Lopes B., Houpt E.R. Calcified neurocysticercus, perilesional edema, and histologic inflammation. Am J Trop Med Hyg. 2014;90:318-321.
  • [39] Del Brutto O.H., Issa N.P. Focal seizures with corresponding neuroimaging and electroencephalographic findings in a patient with scolex remnants within a calcified cysticercus. Am J Trop Med Hyg. 2018;99:815-816.
  • [40] Kahn M.S., Kranjac D., Alonzo C.A., Haase J.H., Cedillos R.O., McLinden K.A. Prolonged elevation in hippocampal Aβ and cognitive deficit following repeated endotoxin exposure in the mouse. Behav Brain Res. 2012;229:176-184.
  • [41] Mejia Maza A.J., Carmen-Orozco R.P., Carter E., Dávila D.G., Castillo G., Morales J.D. Axonal swelling and spheroids: a new insight into the pathology of neurocysticercosis. Brain Pathol. 2018;29:425-436.
  • [42] Baudry M., Gall C., Kessler M., Alapour H., Lynch G. Denervation-induced decrease in mitochondrial calcium transport in rat hippocampus. J Neurosci. 1983;3:252-259.
  • [43] Boutet C., Chupin M., Colliot O., Sarazin M., Mutlu G., Drier A. Alzheimer's Disease Neuroimaging Initiative, 2012. Is radiological evaluation as good as computer-based volumetry to assess hippocampal atrophy in Alzheimer's disease? Neuroradiology. 2012;54:1321-1330.
  • [44] Garcia H.H., Rodriguez S., Gilman R.H., Gonzalez A.E., Tsang V.C.W. Neurocysticercosis: is serology useful in the absence of brain imaging? Trop Med Int Health. 2012;17:1014-1018.